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Jastrzębska, M.; Chrobak, E.; Bębenek,
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Abstract: Lipophilicity is one of the most important parameters determining the pharmacodynamic
and pharmacokinetic properties, as well as the toxicity of many compounds. The subject of the
research was to determine the lipophilicity of betulin-1,4-quinone hybrids using thin layer chro-
matography in reverse phase system and computer programs to calculate its theoretical models. The
correlation between the experimental and theoretical values of lipophilicity was analyzed. Lipinski’s
and Veber’s rules, as well as penetration through the blood–brain barrier were also determined
using computer programs. For all of the analyzed values, a similarity analysis was performed.
The dendrograms for the experimental and theoretical lipophilicity show that there is a correlation
between them. However, the dendrograms for the experimental lipophilicity and pharmacokinetic
parameters indicate that there is no correlation between the structure and the pharmacological
properties. Hybrids exhibit a high biological activity against cancer cell lines, with a high level of
NAD[P]H-quinone oxidoreductase (NQO1) protein. The enzymatic assay used has shown that these
compounds are good NQO1 substrates, as evidenced by the increasing metabolic rates relative to
that of streptonigrin. The similarity analysis has also shown that there is no correlation between
lipophilicity and biological activity for the tested compounds.
Keywords: lipophilicity; betulin; 5,8-quinolinedione; NQO1 protein; ADMET
1. Introduction
Lipophilicity is one of the most important parameters determining the pharmaco-
dynamic, pharmacokinetic, and toxicity parameters of many compounds. It determines
the affinity of the molecule for the organic phase, which relates to the intermolecular
interactions occurring between the solute and solvent molecules [1,2]. Lipophilicity can
be determined by both direct and indirect methods. One of the direct methods is the
shake-flask procedure, which determines lipophilicity as the relationship of the concen-
tration of a compound in n-octanol and water. This method gives encouraging results,
but it has many disadvantages, such as a tedious process, being time-consuming, a large
amount of compound needed, and the requirement of a compound with a high purity.
The indirect methods are based on chromatographic techniques, likes reversed-phase thin
layer chromatography (RP-TLC), normal-phase thin layer chromatography (NP-TLC), and
high-performance liquid chromatography (HPLC). The easy experimental procedure, low
cost, and ability to test multiple compounds in a single run make RP-TLC the most used
method to determine lipophilicity [2–8].
Betulin 1, derived from white species of birch bark, exhibits a wide spectrum of activity,
including anticancer, antimicrobial, anti-viral, and anti-inflammatory properties. The
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chemical structure of betulin 1 contains four six-membered rings and one five-membered
ring. Additionally, in their structure, there are two hydroxyl groups at the C-3 and C-28
positions, and an isopropenyl group at the C-19 position (Figure 1). Modification at these
positions can lead to new semi-synthetic derivatives, which exhibit a better biological
activity and bioavailability [9,10].
Figure 1. Structure of betulin 1.
Many articles on new hybrids of botulin, formed by combinations with other bioactive
substances, like coumarin acid, ferrocene acid, artemisinin acid, and azidothymidine, have
appeared in the literature in recent years. The combination of two active substances results
in new hybrids with a better activity and low toxicity [11–15].
The lipophilicity of betulin derivatives was first described by Achrem-Achremowicz.
This research showed that the lipophilic parameter depends on the type of substituent at the
C-3 and C-28 positions, but the pH of the mobile phase does not affect the lipophilicity [16].
According to the literature data, a relationship between the structure and lipophilicity of
different mono- and di-substituted derivatives of betulin was found. This research showed
that the substituent significantly affects the partition coefficient (log P). Moreover, the
log P value was also strongly affected by different pharmacokinetic properties, like polar
surface, polarizability, molecular volume, and molecular refraction. In many cases, no
correlation between the experimental lipophilicity and biological activity of the compounds
was found [4,6,17,18].
The present study aimed to determine the experimental and theoretical values of
lipophilicity for betulin-1,4-quinone hybrids. The cluster analyses for the lipophilicity of
hybrids allowed us to determine the relationship between the structure and lipophilic
properties. Moreover, the correlation between the lipophilicity and pharmacokinetic prop-
erties was also analyzed. This study also conducted an analysis of the relationship between
the biological properties, like anticancer activity and NAD(P)H:quinone oxidoreductase
(NQO1), and lipophilicity of hybrids.
2. Materials and Methods
2.1. Betulin-1,4-quinone Hybrids
The analyzed compounds (2–16) were synthesized according to the procedure de-
scribed in the literature [19]. The chemical structure of the hybrids is presented in Table 1.
Briefly, betulin 1 and its derivatives were combined with 1,4-quinone in the presence of
potassium carbonate in tetrahydrofuran. The structures of hybrids 2–16 were confirmed by
spectroscopic methods, such as 1H NMR, 13C NMR, IR, and mass spectrometric (HR-MAS).
The spectral data are consistent with those published in the literature [19].
2.2. Chromatographic Analysis
The lipophilic descriptor was determined using RP-TLC. A stationary phase was
obtained by impregnating a silica gel RP-18 F254S layer with un-polar silicone oil. The
(tris-hydroxymethyl)aminomethane (0.2 M, pH = 7.4) with acetone was used as the mobile
phase. The percentage of acetone volume was varied within the range of 65–90% in 5%
increments. Chromatographic chambers were filled with 60 mL of the mobile phase were
and saturated with the vapors for 1h.
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Table 1. The chemical structure of hybrids 2–16.
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2.2. Chromatographic Analysis 
The lipophilic descriptor was determined using RP-TLC. A stationary phase was ob-
tained by impregnating a silica gel RP-18 F254S layer with un-polar silicone oil. The (tris-
hydroxymethyl)aminomethane (0.2 M, pH = 7.4) with acetone was used as the mobile 
phase. The percentage of acetone volume was varied within the range of 65–90% in 5% 
increments. Chromatographic chambers were filled with 60 mL of the mobile phase were 
and saturated with the vapors for 1h. 
Compounds 1–16 were dissolved in chloroform (2.0 mg/mL), and a 2 µL solution of 
the sample was applied on the chromatographic plates using a micropipette. The plates 
were placed in chromatographic chambers. The plates were developed up to a distance of 
8.0 cm and then dried on a hot plate. Spots were visualized by spraying with 10% ethanol 
solution of sulphuric acid (VI) and then heated up to 110 °C. 
The obtained values for the retardation factor (Rf) were converted to the RM parame-
ter according to Equation (1): 
RM = log (
1
Rf
− 1) (1) 
The RM parameters were calculated for every concentration of acetone and were ex-
trapolated to zero concentration of an organic component in the mobile phase. The chro-
matographic parameter of lipophilicity (RM0) was calculated using the Soczewiński–
Wachtmeister’s Equation (2),as follows: 
RM = RM0 + 𝑏𝐶 (2) 
where C is the concentration of acetone in the mobile phase, while b is the slope of the 
regression plot. 
The obtained RM0 and b values were used to determine the chromatography hydro-
phobic index (0) according to Equation (3): 




2.3. Computational Analysis 
The theoretical value of the lipophilicity descriptor for hybrids 2–16 and betulin 1 
were determined using various online tools and available software, including ALOGPs, 
ACLOGP, ALOGP, miLogP, XLOGP2, XLOGP3, ACD/logP, and MolLogP. Each program 
uses a different calculation method, but all of them take into consideration parameters 
related to the chemical structure [20–23]. The pharmacokinetic parameters were calcu-
lated using the pkCMS software [24]. 
2.4. Enzymatic Assay 
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2.3. Computational Analysis
The theoretical value of the lipophilicity descriptor for hybrids 2–16 and betulin 1
were determined using various online tools and available software, including ALOGPs,
ACLOGP, ALOGP, miLogP, XLOGP2, XLOGP3, ACD/logP, and MolLogP. Each program
uses a different calculation method, but all of them take into consideration parameters
related to the chemical structure [20–23]. The pharmacokinetic parameters were calculated
using the pkCMS software [24].
2.4. Enzymatic Assay
Compounds 2–16 (10 µmol/L) were tested as NQO1 substrates using a NADPH recy-
cling assay, as described in the literature [25,26]. The recombinant NQO1 (DT-diaphorase,
EC 1.6.5.5, human recombinant, Sigma-Aldrich, Saint Louis, MO, USA) was used, and the
oxidation of NADPH to NADP+ was measured at an absorption wavelength of 340 nm on
a BioTek 800TS microplate reader (BioKom, Janki, Poland). Compounds were dissolved in
dimethyl sulfoxide (2 µL) and then added to a 96-wall plate. NADPH (400 µmol/L) and
NQO1 (1.4 µg/mL) in a 50 mmol/L potassium phosphate buffer (pH = 7.4) were added to
each well (198 µL; Nunc Thermo Fisher Scientific, Waltham, MA, USA). Once the 96-well
plate was filled with the assay solutions, excluding the NADPH solution, it was placed into
the instrument and left to sit for 2 min before starting the measurements. The enzyme reac-
tion was initiated by automated dispensing of the NADPH solution into the wells, and data
were recorded at 10 s intervals for 10 min at 25 ◦C. The linear portion of the absorbance vs.
time graphs (the first 20 s to 1 min) was fitted, and the slops were calculated (velocity). The
NADPH oxidation rates were compared with the reactions lacking compounds. The initial
velocities were calculated and data were expressed as µmol NADPH/µmol NQO1/min.
All of the reactions were carried out at least in triplicate.
2.5. Correlation and Cluster Analysis
Based on the experimental and theoretical values of lipophilicity, as well as the en-
zymatic activity and molecular descriptor values, correlation and cluster analyses were
performed. All data used for cluster analysis were standardized, and the cluster analysis
was based on the Euclidean distance, using Ward’s method. The analysis was carried out
using Statistica 13.1 software.
3. Results and Discussion
Hybrids 2–16 and betulin 1 were analyzed using the RP-TLC method, and the RM0
and b parameters were calculated based on Equations (1) and (2). The hydrophobic index
(φ0) for each compound was calculated according to Equation (3) (Table 2).
Table 2. The experimental values of the lipophilicity (RM0 and logPTLC) and hydrophobic index (φ0)
for compounds 1–16.
Compound RM0 b r SD logPTLC φ0
1 4.54 −0.05 0.979 0.028 5.34 90.37
2 5.49 −0.06 0.995 0.022 6.36 92.52
3 6.52 −0.07 0.994 0.023 7.46 93.10
4 6.42 −0.07 0.996 0.015 7.36 89.31
5 6.62 −0.07 0.994 0.021 7.58 93.69
6 5.86 −0.07 0.998 0.012 6.75 95.74
7 5.69 −0.06 0.992 0.023 6.58 95.74
8 6.49 −0.07 0.997 0.019 7.43 90.72
9 6.42 −0.07 0.996 0.009 7.36 90.92
10 6.80 −0.07 0.995 0.025 7.77 95.00
11 6.77 −0.08 0.994 0.011 7.74 90.71
12 6.46 −0.07 0.987 0.027 7.41 92.85
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Table 2. Cont.
Compound RM0 b r SD logPTLC φ0
13 7.12 −0.07 0.995 0.023 8.12 93.10
14 7.13 −0.07 0.995 0.019 8.14 88.67
15 6.82 −0.08 0.982 0.014 7.19 91.54
16 6.26 −0.07 0.973 0.029 7.80 87.09
b is the slope, r is the correlation coefficient, and SD is the standard deviation for the linear relationship of
RM = RM0 + bC.
In order to obtain the logPTLC value, a calibration curve used needed. As stan-
dard substances, acetanilide, 4-bromoacetophenone, benzophenone, anthracene, dibenzyl,
9-phenylanthracene, and dichlorodiphenyltrichloroethane (DDT) were used, for which the
literature logPlit values were in the range of 1.21–6.38 [27,28]. The RM0 for each standard
compound was determined in the same condition as for hybrids 2–16 (Table 3).
Table 3. The experimental (RM0 and logPTLC) and literature (logPlit) values of the standard compounds.
Compound logPlit RM0 b r SD logPTLC
Acetanilide 1.21 0.68 −0.02 0.985 0.015 1.17
4-Bromoacetophenone 2.43 1.87 −0.02 0.981 0.018 2.46
Benzophenone 3.18 2.42 −0.03 0.992 0.013 3.05
Anthracene 4.45 4.08 −0.05 0.970 0.022 4.84
Dibenzyl 4.79 4.11 −0.04 0.972 0.023 4.87
9-Phenylanthracene 6.01 4.87 −0.06 0.985 0.019 5.69
DDT 6.38 5.50 −0.06 0.975 0.019 6.37
b is the slope and r is the correlation coefficient for the linear relationship for RM = RM0 + bC.
A linear relation between the literature logPlit and the experimental RM0 is described
by Equation (4).
logPTLC = 1.0777 RM0 + 0.4407 (r = 0.993; SD = 0.138) (4)
The calibration curve was used to calculate the logPTLC value of hybrids 2–16 and
betulin (1) (Table 2). In the group of tested compounds, betulin 1 showed the lowest
lipophilicity parameter (logPTLC = 5.34). The introduction of 1,4-quinone moiety led to an
increase in lipophilicity, resulting in logPTLC in the range of 6.36–8.12.
In the group of betulin-5,8-quinolinedione hybrids (2–6), the lowest lipophilicity
showed compound 2 containing the hydroxyl group at the C-3 position of the betulin
moiety. The replacement of this hydroxyl group with an acetyl group caused an increase in
lipophilicity. A comparison of logPTLC for hybrids 3 and 4 showed that the elongation of
the chain at the C-28 position created in an increase in lipophilicity. For hybrids 2–6,
the order of the logPTLC decrease was as follows: 5 > 4 = 3 > 6 > 2. The introduc-
tion of the methyl group at the C-2′ position of 5,8-quinolinedione moiety, as seen for
compounds 7–11, led to a slight increase in lipophilicity. In this group of compounds,
the lowest value of logPTLC was exhibited by hybrid 7. In the series of tested hybrids
(2–16), the highest lipophilicity showed derivatives containing the 1,4-naphthoquinone
moiety (12–16). For 12–16, the lowest lipophilicity was exhibited by compound 15, which
contained the propynoiloxy moiety at the C-28 position of betulin. The obtained re-
sults show that lipophilicity depends on the type of 1,4-quinone, and follows the order
5,8-quinolinedione > 2-methyl-5,8-qinolinedione > 1,4-naphthoquinone (Figure 2).
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Figure 2. The profile of changes for the experimental and theoretical lipophilicity for hybrids 1–16.
Hydrophobicity is the capability of non-polar molecules or groups to form an asso-
ciation in water, and is measured by the hydrophobic index (φ0). A higher index means
that the compound is less soluble in water [3,29]. Hybrids 2–16 are characterized by a high
value of φ0 index, which varies in the range of 88.67–95.74. A comparison of the hydropho-
bicity of betulin 1 (φ0 = 87.09) and its derivatives (2–16) shows that the introduction of
1,4-quinone moiety slightly influenced their solubility in water.
The next step of the research was to determine the logP parameter using the available
computer software [20–23]. Depending on the mathematical module of the program
used, the obtained values of the calculated logP covered a wide range, from 5.34 to 13.33
(Table 4).
Table 4. The calculated value of lipophilicity for hybrids 2–16 and betulin 1.
Compound ALOGPs ACLOGP ALOGP miLogP XLOGP2 XLOGP3 ACD/logP MolLogP
1 5.34 5.84 6.31 7.61 7.81 8.28 9.01 7.90
2 6.23 7.15 7.58 8.00 9.37 10.47 10.38 9.40
3 6.77 7.64 7.95 8.53 10.11 11.05 11.28 9.82
4 6.77 7.64 7.95 8.53 10.11 11.05 11.28 9.82
5 6.66 7.09 9.23 8.05 10.39 11.53 12.00 10.20
6 6.69 7.17 7.24 8.15 9.39 10.37 10.92 8.31
7 6.48 7.57 7.86 8.05 9.69 10.87 10.84 9.78
8 7.00 8.05 8.24 8.56 10.43 11.43 11.74 10.21
9 7.00 8.05 8.24 8.56 10.43 11.43 11.74 10.21
10 6.81 7.51 9.51 8.10 10.70 11.93 12.46 10.59
11 6.94 7.59 7.53 8.20 9.71 10.77 11.38 8.69
12 6.47 8.12 8.30 9.01 10.53 11.21 11.71 10.50
13 6.94 8.61 8.68 9.24 11.27 11.78 12.61 10.92
14 6.94 8.61 8.68 9.24 11.27 11.78 12.62 10.92
15 7.02 8.07 9.95 9.03 11.55 12.26 13.33 11.30
16 6.97 8.14 7.97 9.07 10.55 11.11 11.42 9.40
The highest values of lipophilicity were obtained using the ACD/logP program.
However, the values that were the most similar to the experimental ones (logPTLC values),
were found using the ACLOGP program (Figure 2). The presented calculations show that
betulin 1 has the lowest lipophilicity, which is consistent with its logPTLC value (Figure 2).
The introduction of the 1,4-quinone moiety caused an increase in lipophilicity, which is
consistent with experimental results. As shown in Figure 2, hybrids 5, 10, and 15 had the
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highest calculated value of lipophilicity. In addition, the lowest values were found for
compounds 2, 6, and 11. These results are similar to the experimental results. In each group
of compounds, there were hybrids with the same molecular formula, like 3 and 4, 8 and
9, and 13 and 14 (Table 4 and Figure 2). In these cases, the calculated lipophilicity was
the same for both compounds, regardless of the calculation method, but the experimental
lipophilicity was different. These results show that in many cases, the theoretical calculation
is not enough for the evaluation of the lipophilic parameters of compounds.
Table 5 presents the parameters of the correlation equation between logPTLC and the
calculated logP. The correlation coefficients are high (r = 0.864 − 0.815) for most programs.
The exceptions are ALOGP, milogP, and MolLogP, for which the r value varied in the range
of 0.702–0.638.
Table 5. Correlation equations for the relationship between the experimental (LogPTLC) and theoreti-
cally (LogPcalc) values of lipophilicity for compounds 1–16.
Program Correlation Equation r SD
ALOGPS logPTLC = 1.454 LogPcalc − 2.458 0.864 0.373
ACLOGP logPTLC = 0.871 LogPcalc + 0.584 0.824 0.421
ALOGP logPTLC = 0.513 LogPcalc + 3.068 0.638 0.571
milogP logPTLC = 1.001 LogPcalc − 1.236 0.702 0.528
XLOGP2 logPTLC = 0.666 LogPcalc + 0.475 0.842 0.401
XLOGP3 logPTLC = 0.653 LogPcalc + 0.037 0.829 0.415
ACD/logP logPTLC = 0.575 LogPcalc + 0.633 0.815 0.430
MolLogP logPTLC = 0.482 LogPcalc + 2.513 0.642 0.569
The cluster analysis (similarity analysis) was performed for all of the results, for
both the experimental and theoretical values of lipophilicity. The results are presented in
Figure 3.
Figure 3. Similarity analysis of the experimental and theoretical values of lipophilicity for hybrids
2–16 and betulin 1.
The similarity analysis shows three main clusters. The first consists of compounds 5,
10, and 15; the second 6, 11, and 16; and the third 1–4, 7–9, and 12–14. In the first and second
clusters, hybrids are arranged according to the type of betulinyloxy fragment, which means
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that hybrids with 28-propynoyl-3-betulinyloxy and 3,28-diacetyl-30-betulinyloxy moieties
have been recognized, respectively. In these two clusters, a strong relationship between
lipophilicity and the structure of compounds can be observed. Derivatives 5, 10, and 15
have a different 1,4-quinone moiety at the C-3 position, while 6, 11, and 16 show structural
similarity associated with the presence of the 1,4-quinone moiety at the C-30 position.
The third biggest cluster can be divided into two subclusters, and betulin (1), which
differed from the others in this group. The first subcluster consists of 1,4-naphthoquinone
compounds 12–14, and the second one of 5,8-quinolinedione (2–4) and 2-methyl-5,8-
quinolinedione (7–9) hybrids. Hybrids 2–4 and 7–9 show a similar value of lipophilicity.
The similarity analysis shows a strong correlation between the lipophilicity and structure
of the tested compounds (2–16).
The physicochemical parameters, such as molecular mass (M), topological polar
surface area (TPSA), number of the donors (nHD) and acceptors (nHA) of the hydrogen
bond, and number of rotatable bonds (nRT), are usually used to assess the absorption,
distribution, metabolism, and excretion of the compound in the biological system [30–32].
An important property of the synthesized compounds is their penetration through the
blood–brain barrier (BBB), which allows for predicting their neurotoxicity. All parameters
were calculated using pkCMS software [24]. The results are presented in Table 6.
Table 6. The parameters determined by computational methods such as molecular mass (M), number
of the donors (nHD) and acceptors (nHA) of the hydrogen bond, number of rotatable bonds (nRT),
topological polar surface area (TPSA), and penetration drug by the blood-brain barrier (BBB; logBB).
Compound M (g/mol) nHD nHA nRT TPSA (Å2) logBB
1 442.73 2 2 2 40.46 −0.421
2 634.29 1 5 4 75.96 −0.335
3 676.32 0 6 6 82.03 −0.674
4 676.32 0 6 6 82.56 −0.667
5 686.32 0 6 7 82.56 −0.634
6 734.36 0 8 9 108.86 −1.124
7 648.31 1 5 4 75.96 −0.344
8 690.35 0 6 6 82.56 −0.683
9 690.35 0 6 6 82.56 −0.676
10 700.34 0 6 7 82.56 −0.643
11 748.38 0 8 9 108.86 −1.133
12 633.30 1 4 4 63.60 −0.524
13 675.33 0 5 6 69.67 −0.439
14 675.33 0 5 6 69.67 −0.434
15 685.33 0 5 7 69.67 −0.401
16 733.37 0 7 9 95.97 −0.893
Lipinski was the first researcher who studied the penetration of different compounds
through biological membranes. He found that this penetration depends on the molecular
mass of the compound, its lipophilicity, and the number of the donors and acceptors of
hydrogen. Veber’s rules are a modification of Lipiński’s rules, and they introduce some
changes, namely, the molecular mass has been replaced by the topological polar surface
area and the number of rotatable bonds has been added [33,34]. Betulin 1 meets the
mass criterion (M < 500 g/mol), while the introduction of the 1,4-quinone moiety leads
to an increase in molecular mass above 500 g/mol. All compounds 1–16 have less than
5 hydrogen bond donors (nHD = 0–2), less than 10 hydrogen bond acceptors (nHA = 2–8),
and less than 10 rotatable bonds (nRT = 2–9), which means that these compounds meet
Veber’s criteria. A comparison of the nHD and nRT of betulin 1 and hybrids 2–16 shows
that the introduction of the 1,4-quinone moiety causes an increase in both parameters. The
TPSA of compounds 1–16 varies in the range of 40.46–108.86 Å2, which determines the
high oral bioavailability [34]. According to the literature, if for a given compound the
logBB > 0.3, it is considered to have the possibility of rapid penetration by the blood–brain
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barrier, if logBB < −1, there is a poor distribution to the brain [35,36]. The logBB values
for hybrids 2–16 are lower than 0.3, which suggests that these compounds could have a
low permeability through BBB. Moreover, two of them, 6 and 11, show log BB < −1, which
means they do not penetrate the central nervous system.
The correlation between logPTLC and the calculated parameters is characterized by
low regression coefficients (r = 0.066–0.624). The results indicate that there is no significant
relationship between the lipophilicity and pharmacokinetic parameters. As an additional
description of the analyzed hybrids (2–16), cluster analysis was performed, taking into
account the experimental lipophilicity values and the physicochemical (M, nHA, nHD, nRT,
and TPSA) and pharmacokinetics properties (logBB). The results are presented in Figure 4.
Figure 4. Similarity analysis for hybrids 2–16 investigated based on the experimental lipophilicity
and the physicochemical (M, nHD, nHA, nRT, and TPSA) and pharmacokinetic properties (logBB).
As can be seen in Figure 4, there are several clusters. Compounds 6, 11, and 16,
containing the 1,4-quinone moiety at the C-30 of 3,24-diacetyl-30-betulinyloxy, form the
first cluster. Hybrids 13, 14, and 15 with the 1,4-naphthoquinone fragment at different
positions of the betulinyloxy moiety, form another cluster. Derivatives 3–5 and 8–10
containing the 5,8-quinolinedione or 2-methyl-5,8-quinolinedione moiety in their structure,
are the next cluster. The last cluster is formed by compounds with the 28-betulinyloxy
moiety. The obtained results show that there is no correlation between the lipophilicity and
pharmacokinetics parameters for the tested hybrids (2–16).
The next step of the research was the analysis of the biological activity of hybrids 2–16.
It was found that derivatives 2–16, which exhibit a high anticancer activity against the lung
cancer cell line (A549), also have a high level of the NOQ1 protein (Table 7) [19]. For this
reason, all compounds were tested as a substrate of NAD[P]H-quinone oxidoreductase
1 (NQO1). In this assay, hybrids at a concentration of 10 µmol/L were incubated with
human NQO1 and NADPH. Streptonigrin was used as a reference compound. The results
of the quinone reduction are expressed in units µmol·L−1 NADPH oxidized·min−1·µmol−1
NQO1 in Table 7.
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Table 7. The NAD[P]H-quinone oxidoreductase 1 (NQO1) activity of hybrids 2–16 monitored at an
absorbance at A340 nm.




2 8.58 ± 1.70 1685 ± 12
3 14.34 ± 0.31 1451 ± 9
4 13.46 ± 1.45 1419 ± 6
5 0.45 ± 0.20 2192 ± 21
6 3.30 ± 0.48 1505 ± 15
7 1.62 ± 0.91 1705 ± 19
8 0.64 ± 0.04 2008 ± 19
9 0.59 ± 0.13 1744 ± 14
10 18.41 ± 1.91 1784 ± 7
11 0.84 ± 0.01 1839 ± 23
12 10.63 ± 1.45 1459 ± 18
13 1.15 ± 0.10 1784 ± 6
14 0.77 ± 0.12 2009 ± 17
15 1.28 ± 0.06 1870 ± 13
16 53.9 ± 8.02 1040 ± 9
Streptonigrin NO 621 ± 32
Neg.—IC50 > 30 µM; NO—not test.
Hybrids 2–16 show good reduction rates using NQO1, indicating that these com-
pounds are good substrates for this protein. They show also higher metabolic rates
(1040–2192 µmolNADPH/µmolNQO1/min) in comparison with streptonigrin
(621 µmolNADPH/µmolNQO1/min). In the group of 5,8-quinolinedione derivatives
(2–6), hybrid 5 exhibits the highest enzymatic conversion rates, which are 3.5-time higher
than for streptonigrin. Moreover, this compound exhibits a high activity against A549
cells. The introduction of the ethanoyl group at the C-28 position of botulin, instead of
the propynoyl group (4 and 5), causes a decrease in the enzymatic conversion rates. A
comparison of the 5,8-quinolinedione (2–6) and 2-methyl-5,8-quinolinedione (7–11) hybrids
suggests that the introduction of the methyl group at the 5,8-quinonedione moiety causes
an increase in enzymatic conversion rates. The exceptions are compounds 5 and 10, for
which the introduction of the 5,8-quinolinedione moiety gives more active derivatives than
those with the 2-methyl-5,8-quinolinedione moiety. In the group of the 1,4-naphthoquinone
compound (12–16), derivative 14 shows the highest enzymatic conversion rates. The cor-
relation of the NQO1 activity with IC50 values against A549 cells shows high regression
coefficients (r = 0.773), suggesting that for this group of analogs, the anticancer activity
refers to its interaction with the NQO1 protein.
The next step in the research was the analysis of the correlation between the experimen-
tal lipophilicity (logPTLC), cytotoxic activity, and NQO1 activity. The calculated regression
coefficient was low (r = 0.140–0.174), which means there is no significant relationship be-
tween lipophilicity and activity. The next similarity analysis was done for the experimental
lipophilicity and biological activity (IC50 and NQO1 activity; Figure 5).
Figure 5 shows that there are two main clusters. The first consists of compounds with
a low value of NQO1 activity, like 3, 4, 6, 12, and 16. The second consists of hybrids 2,
5, 7–11, and 13–15; however, it is difficult to find the similarity in the structure of these
derivatives. This result shows that there is no relationship between lipophilicity and the
biological activity of hybrids 2–16.
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Figure 5. Similarity analysis for hybrids 2–16 investigated based on the experimental lipophilicity
and biological activity (IC50 and NQO1 activity).
4. Conclusions
In the presented study, the lipophilicity of betulin-1,4-quinone hybrids was determined
and analyzed in terms of their structure, pharmacokinetic parameters, and anticancer and
enzymatic activity. The introduction of 1,4-quinone moiety to the betulin structure caused
an increase in lipophilicity. The cluster analysis showed that there is a strong relationship
between the structure of compounds and both their experimental and calculated lipophilic-
ity, which can serve to predict these values when designing new compounds. Additionally,
Lipinski’s and Veber’s rules, supplemented by blood–brain penetration properties, were
used to determine the bioavailability of hybrids 2–16. The obtained parameters suggest
that the oral application could have some limitations because of the high value of the
lipophilicity and molecular mass. The similarity analyses showed that lipophilicity does
not correlate with the pharmacokinetic parameters.
The enzymatic study showed that hybrids 2–16 can be characterized as efficient sub-
strates for the NQO1 protein. The correlation between the anticancer activity against lung
cancer (A549) and the NQO1 activity shows that anticancer activity refers to its interaction
with the NQO1 protein. Based on the similarity analysis, it has been found that there is no
correlation between the biological activity and lipophilicity of the tested compounds.
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